Table 1.
Demographic characteristics of the participants
| Experimental group (n = 66) | Control group (n =60) | |
|---|---|---|
| Age (years) | ||
| Mean ± S.D | 51.5 ± 9.0 | 54.0 ± 10.2 |
| Gender (%) | ||
| Male | 45.5 | 41.7 |
| Female | 54.6 | 58.3 |
| Number of teeth (n) | ||
| Mean ± S.D | 23.6 ± 5.7 | 24.7 ± 5.6 |
| Diabetic treatment (%) | ||
| No | 21.2 | 20.0 |
| Medicine | 78.8 | 80.0 |
| Medical change (%) | ||
| No | 72.7 | 78.3 |
| Increase | 13.6 | 16.7 |
| Decrease | 13.7 | 5.0 |
| % of sites with BOP | ||
| Mean ± S.D | 51.2 ± 29.4 | 51.8 ± 30.0 |
| % of sites with PD | ||
| 1–3 mm | 54.3 ± 21.8 | 54.4 ± 21.9 |
| 4–6 mm | 40.4 ± 17.4 | 38.6 ± 16.0 |
| ≥ 7 mm | 5.2 ± 7.3 | 7.0 ± 10.4 |
| PD (sites with initial PD 1–3 mm) | ||
| Mean ± S.D (mm) | 2.6 ± 0.2 | 2.6 ± 0.2 |
| PD (sites with initial PD 4–6 mm) | ||
| Mean ± S.D (mm) | 4.8 ± 0.3 | 4.7± 0.3 |
| PD (sites with initial PD ≥ 7 mm)* | ||
| Mean ± S.D (mm) | 7.4 ± 0.5 | 7.4 ± 0.6 |
| % of sites with CAL | ||
| 1–2 mm | 23.0 ± 16.2 | 22.4 ± 18.6 |
| 3–4 mm | 39.3 ± 14.0 | 39.2 ± 16.0 |
| ≥ 5mm | 37.5 ± 25.4 | 38.3 ± 28.3 |
| CAL (sites with initial PD 1–3 mm) | ||
| Mean ± S.D (mm) | 3.1 ± 1.0 | 3.2 ± 1.0 |
| CAL (sites with initial PD 4–6 mm) | ||
| Mean ± S.D (mm) | 5.1 ± 1.0 | 5.1 ± 1.2 |
| CAL (sites with initial PD ≥ 7mm)* | ||
| Mean ± S.D (mm) | 7.7 ± 1.4 | 8.1 ± 1.7 |
| REC (sites with initial PD 1–3 mm) | ||
| Mean ± S.D (mm) | −0.5 ± 0.8 | −0.6 ± 0.9 |
| REC (sites with initial PD 4–6 mm) | ||
| Mean ± S.D (mm) | −0.3 ± 0.9 | −0.4 ± 1.1 |
| REC (sites with initial PD ≥ 7mm) * | ||
| Mean ± S.D (mm) | −0.4 ± 1.4 | −0.7 ± 1.5 |
| HbA1c (%) | ||
| Mean ± S.D (minimum–maximum) | 9.0 ± 2.3 (5.7 – 16) | 8.4 ± 2.0 (5.8–14.2) |
All comparisons between test and control groups: non-significant
*
Experiment group (n = 48), control group (n = 42)